These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
293 related articles for article (PubMed ID: 11363967)
1. MAC management. PI Perspect; 1996 Nov; (No 20):16-7. PubMed ID: 11363967 [TBL] [Abstract][Full Text] [Related]
2. Progress report: prophylaxis and therapy for MAC. Currier J AIDS Clin Care; 1996 Jun; 8(6):45-8. PubMed ID: 11363599 [TBL] [Abstract][Full Text] [Related]
3. Advances in prevention and treatment of MAC. Cheng B PI Perspect; 1995 Dec; (no 17):11. PubMed ID: 11363104 [TBL] [Abstract][Full Text] [Related]
4. A comparison of two regimens for the treatment of Mycobacterium avium complex bacteremia in AIDS: rifabutin, ethambutol, and clarithromycin versus rifampin, ethambutol, clofazimine, and ciprofloxacin. Canadian HIV Trials Network Protocol 010 Study Group. Shafran SD; Singer J; Zarowny DP; Phillips P; Salit I; Walmsley SL; Fong IW; Gill MJ; Rachlis AR; Lalonde RG; Fanning MM; Tsoukas CM N Engl J Med; 1996 Aug; 335(6):377-83. PubMed ID: 8676931 [TBL] [Abstract][Full Text] [Related]
5. MAC prophylaxis revisited. Torres G GMHC Treat Issues; 1996 Apr; 10(4):6-7, 10. PubMed ID: 11363706 [TBL] [Abstract][Full Text] [Related]
6. Interventions for the prevention of mycobacterium avium complex in adults and children with HIV. Uthman MM; Uthman OA; Yahaya I Cochrane Database Syst Rev; 2013 Apr; (4):CD007191. PubMed ID: 23633339 [TBL] [Abstract][Full Text] [Related]
7. Prevention strategies for Mycobacterium avium-intracellulare complex (MAC) infection. A review of recent studies in patients with AIDS. Cohn DL Drugs; 1997; 54 Suppl 2():8-15; discussion 28-9. PubMed ID: 9358195 [TBL] [Abstract][Full Text] [Related]
9. Antivirals key to MAC prevention regimen. AIDS Alert; 1996 Sep; 11(9):101-3. PubMed ID: 11363722 [TBL] [Abstract][Full Text] [Related]
10. Clarithromycin and ethambutol with or without clofazimine for the treatment of bacteremic Mycobacterium avium complex disease in patients with HIV infection. Chaisson RE; Keiser P; Pierce M; Fessel WJ; Ruskin J; Lahart C; Benson CA; Meek K; Siepman N; Craft JC AIDS; 1997 Mar; 11(3):311-7. PubMed ID: 9147422 [TBL] [Abstract][Full Text] [Related]
11. Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. Benson CA; Kessler HA; Pottage JC; Trenholme GM Arch Intern Med; 1991 Mar; 151(3):582-5. PubMed ID: 2001140 [TBL] [Abstract][Full Text] [Related]
12. A randomized, placebo-controlled study of rifabutin added to a regimen of clarithromycin and ethambutol for treatment of disseminated infection with Mycobacterium avium complex. Gordin FM; Sullam PM; Shafran SD; Cohn DL; Wynne B; Paxton L; Perry K; Horsburgh CR Clin Infect Dis; 1999 May; 28(5):1080-5. PubMed ID: 10452638 [TBL] [Abstract][Full Text] [Related]
13. Tolerability Outcomes of American Thoracic Society/Infectious Diseases Society of America Guideline-Recommended Multidrug Antibiotic Treatment for Mycobacterium avium Complex Pulmonary Disease in US Medicare Beneficiaries With Bronchiectasis. Ku JH; Henkle E; Carlson KF; Marino M; Brode SK; Marras TK; Winthrop KL Chest; 2024 May; 165(5):1058-1069. PubMed ID: 38086472 [TBL] [Abstract][Full Text] [Related]
14. A prospective randomized trial of four three-drug regimens in the treatment of disseminated Mycobacterium avium complex disease in AIDS patients: excess mortality associated with high-dose clarithromycin. Terry Beirn Community Programs for Clinical Research on AIDS. Cohn DL; Fisher EJ; Peng GT; Hodges JS; Chesnut J; Child CC; Franchino B; Gibert CL; El-Sadr W; Hafner R; Korvick J; Ropka M; Heifets L; Clotfelter J; Munroe D; Horsburgh CR Clin Infect Dis; 1999 Jul; 29(1):125-33. PubMed ID: 10433575 [TBL] [Abstract][Full Text] [Related]
15. Activity of moxifloxacin by itself and in combination with ethambutol, rifabutin, and azithromycin in vitro and in vivo against Mycobacterium avium. Bermudez LE; Inderlied CB; Kolonoski P; Petrofsky M; Aralar P; Wu M; Young LS Antimicrob Agents Chemother; 2001 Jan; 45(1):217-22. PubMed ID: 11120969 [TBL] [Abstract][Full Text] [Related]
16. Clarithromycin or rifabutin alone or in combination for primary prophylaxis of Mycobacterium avium complex disease in patients with AIDS: A randomized, double-blind, placebo-controlled trial. The AIDS Clinical Trials Group 196/Terry Beirn Community Programs for Clinical Research on AIDS 009 Protocol Team. Benson CA; Williams PL; Cohn DL; Becker S; Hojczyk P; Nevin T; Korvick JA; Heifets L; Child CC; Lederman MM; Reichman RC; Powderly WG; Notario GF; Wynne BA; Hafner R J Infect Dis; 2000 Apr; 181(4):1289-97. PubMed ID: 10762562 [TBL] [Abstract][Full Text] [Related]
17. Symptomatic and health status outcomes in the Canadian randomized MAC treatment trial (CTN010). Canadian HIV Trials Network Protocol 010 Study Group. Singer J; Thorne A; Khorasheh S; Raboud JM; Wu AW; Salit I; Tsoukas CM; Lemieux C; Shafran SD Int J STD AIDS; 2000 Apr; 11(4):212-9. PubMed ID: 10772083 [TBL] [Abstract][Full Text] [Related]
18. Hold the big MAC. Young A Notes Undergr; 1996 Apr; (no 32):6. PubMed ID: 11363450 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease. Koh WJ; Jeong BH; Jeon K; Lee SY; Shin SJ Am J Respir Crit Care Med; 2012 Oct; 186(8):797-802. PubMed ID: 22878282 [TBL] [Abstract][Full Text] [Related]
20. Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex. Griffith DE; Brown BA; Cegielski P; Murphy DT; Wallace RJ Clin Infect Dis; 2000 Feb; 30(2):288-92. PubMed ID: 10671330 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]